AKRO
Price
$54.28
Change
+$0.34 (+0.63%)
Updated
Jun 6 closing price
Capitalization
4.31B
61 days until earnings call
ETNB
Price
$10.25
Change
+$0.29 (+2.91%)
Updated
Jun 6 closing price
Capitalization
1.45B
60 days until earnings call
Interact to see
Advertisement

AKRO vs ETNB

Header iconAKRO vs ETNB Comparison
Open Charts AKRO vs ETNBBanner chart's image
Akero Therapeutics
Price$54.28
Change+$0.34 (+0.63%)
Volume$1.47M
Capitalization4.31B
89bio
Price$10.25
Change+$0.29 (+2.91%)
Volume$1.58M
Capitalization1.45B
AKRO vs ETNB Comparison Chart
Loading...
AKRO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ETNB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AKRO vs. ETNB commentary
Jun 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AKRO is a StrongBuy and ETNB is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 08, 2025
Stock price -- (AKRO: $45.32 vs. ETNB: $9.23)
Brand notoriety: AKRO and ETNB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AKRO: 68% vs. ETNB: 67%
Market capitalization -- AKRO: $4.31B vs. ETNB: $1.45B
AKRO [@Biotechnology] is valued at $4.31B. ETNB’s [@Biotechnology] market capitalization is $1.45B. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AKRO’s FA Score shows that 0 FA rating(s) are green whileETNB’s FA Score has 1 green FA rating(s).

  • AKRO’s FA Score: 0 green, 5 red.
  • ETNB’s FA Score: 1 green, 4 red.
According to our system of comparison, AKRO is a better buy in the long-term than ETNB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AKRO’s TA Score shows that 6 TA indicator(s) are bullish while ETNB’s TA Score has 6 bullish TA indicator(s).

  • AKRO’s TA Score: 6 bullish, 4 bearish.
  • ETNB’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, both AKRO and ETNB are a good buy in the short-term.

Price Growth

AKRO (@Biotechnology) experienced а -6.27% price change this week, while ETNB (@Biotechnology) price change was -3.95% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.11%. For the same industry, the average monthly price growth was +10.01%, and the average quarterly price growth was -2.16%.

Reported Earning Dates

AKRO is expected to report earnings on Aug 08, 2025.

ETNB is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+4.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AKRO($4.31B) has a higher market cap than ETNB($1.45B). AKRO YTD gains are higher at: 62.904 vs. ETNB (18.031). AKRO has higher annual earnings (EBITDA): -247.37M vs. ETNB (-361.06M). AKRO has more cash in the bank: 743M vs. ETNB (440M). AKRO (36.5M) and ETNB (37.5M) have identical debt. AKRO (0) and ETNB (0) have equivalent revenues.
AKROETNBAKRO / ETNB
Capitalization4.31B1.45B296%
EBITDA-247.37M-361.06M69%
Gain YTD62.90418.031349%
P/E RatioN/AN/A-
Revenue00-
Total Cash743M440M169%
Total Debt36.5M37.5M97%
FUNDAMENTALS RATINGS
AKRO: Fundamental Ratings
AKRO
OUTLOOK RATING
1..100
75
VALUATION
overvalued / fair valued / undervalued
1..100
42
Fair valued
PROFIT vs RISK RATING
1..100
58
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AKROETNB
RSI
ODDS (%)
Bearish Trend 12 days ago
87%
Bearish Trend 12 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 12 days ago
80%
Bearish Trend 12 days ago
90%
Momentum
ODDS (%)
Bullish Trend 12 days ago
80%
Bullish Trend 12 days ago
82%
MACD
ODDS (%)
Bullish Trend 12 days ago
80%
Bullish Trend 12 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 12 days ago
85%
Bullish Trend 12 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 12 days ago
79%
Bullish Trend 12 days ago
84%
Advances
ODDS (%)
Bullish Trend 18 days ago
82%
Bullish Trend 18 days ago
85%
Declines
ODDS (%)
Bearish Trend 12 days ago
84%
Bearish Trend 13 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 12 days ago
88%
Bearish Trend 12 days ago
90%
Aroon
ODDS (%)
Bullish Trend 12 days ago
77%
Bullish Trend 12 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
AKRO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ETNB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

AKRO and

Correlation & Price change

A.I.dvisor indicates that over the last year, AKRO has been loosely correlated with ETNB. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if AKRO jumps, then ETNB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AKRO
1D Price
Change %
AKRO100%
-1.48%
ETNB - AKRO
60%
Loosely correlated
+0.76%
SLS - AKRO
44%
Loosely correlated
-7.77%
TRDA - AKRO
41%
Loosely correlated
+0.91%
IDYA - AKRO
40%
Loosely correlated
+0.72%
DNLI - AKRO
38%
Loosely correlated
-1.29%
More

ETNB and

Correlation & Price change

A.I.dvisor indicates that over the last year, ETNB has been loosely correlated with AKRO. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if ETNB jumps, then AKRO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ETNB
1D Price
Change %
ETNB100%
+0.76%
AKRO - ETNB
60%
Loosely correlated
-1.48%
IDYA - ETNB
55%
Loosely correlated
+0.72%
DNLI - ETNB
53%
Loosely correlated
-1.29%
CRNX - ETNB
52%
Loosely correlated
+1.39%
COGT - ETNB
51%
Loosely correlated
N/A
More